Leni's Fight: Sanfilippo Syndrome & Gene Therapy Hope

0:00On March 23, Gus and Emily Forsters' two-year-old daughter, Leney, has Sam Filippo syndrome, a rare neurodegenerative disease that strikes about one in 70,000 births. This childhood dementia stems from an enzyme shortage, allowing toxic molecules to build up and damage the brain over time. Kids often look healthy early on, but symptoms hit around age three, leading to losses in speech, mobility, eating, and drinking. No cure exists in the UK, though a promising clinical trial for gene therapy is slated to start in the United States later this year. The parents launch to go fund me to fund access to treatment and are pressing the government for research support to include UK patients. They stress that delays could mean Leney loses key skills in just months, as brain damage becomes permanent. Professor Brian Bigger, from the University of Edinburgh, leads gene therapy efforts targeting blood stem cells, but major funding is needed to launch. Trials. Childhood dementia impacts roughly 240 UK births yearly, and experts say government backing

1:04is essential beyond what charities can. Provide. Meanwhile, calls grow for newborn screening to catch these rare conditions sooner, noting their combined toll on many families. With officials promising faster diagnoses and better care access, the Forester's Hope urgency will speed transformative therapies for kids like Leney.